Psychometric properties of the Persian version of the Time to Relapse Questionnaire (TRQ) in substance use disorder

References

• Mokri A. Brief overview of the status of drug abuse in Iran. Arch Iran Med 2002;5:184–190.
   Google Scholar
• Raisdana F, Nakhjavani AG. The drug market in Iran. ANNALS Am Acad Political Social Sci 2002;582:149–166.
   Web of Science ®Google Scholar
• Alam-mehrjerdi Z, Abdollahi M, Higgs P, Dolan K. Drug use treatment and harm reduction programs in Iran: a unique model of health in the most populated Persian Gulf country. Asian J Psychiatry 2015;16:78–83.
   PubMedGoogle Scholar
• United Nations Office on Drugs and Crime: 2005 World Drug Report VIA.
   Google Scholar
• Nissaramanesh B, Trace M, Roberts M. The rise of harm reduction in the Islamic Republic of Iran. Beckley Foundation Drug Policy Programme, Briefing Paper 2005;8.
   Google Scholar
• Razzaghi E, Rahimi A, Hosseini M, Chatterjee A. Rapid Situation Assessment (RSA) of drug abuse in Iran. Prevention Department, State Welfare Organization, Ministry of Health, IR of Iran and United Nations International Drug Control Program 1999.
   Google Scholar
• Razzaghi E, Rahimi-Movaghar A, Hosseini M, Madani S, Chatterjee A. Rapid Situation Assessment of Drug Abuse in Iran Tehran: Iranian Welfare Organization and UNDCP. 1999. Available at: http://www.unodc.org/pdf/iran/publications/RSA2000SUMMARY.pdf.
   Google Scholar
• Pashaei T, Razaghi OM, Foroushani AR, Tabatabaei MG, Moeeni M, Turner NE, Sharifi V, Shojaeizadeh D. Assessing the validity and reliability of the Farsi version of inventory drug-taking situations. Iran J Psychiatry 2013;8:80.
   PubMedGoogle Scholar
• O’Brien CP. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry 2005;162:1423–1431.
   Google Scholar
• O’Brien C, McLellan AT. Myths about the treatment of addiction. Lancet 1996;347:237–240.
   PubMed Web of Science ®Google Scholar
• Mohammadpoorasl A, Fakhari A, Akbari H, Karimi F, Arshadi Bostanabad M, Rostami F, Hajizadeh M. Addiction relapse and its predictors: A prospective study. J Addict Res Ther 2012;3:1.
   Google Scholar
• Shirinbayan P, Rafiey H, Vejdani Roshan A, Narenjiha H, Farhoudian A. Predictors of retention in methadone maintenance therapy: a prospective multi-center study. Sci Res Essay 2010;5:3231–3236.
   Google Scholar
• Tatari F, Shakeri J, Nasiri A, Ghelichi L, Abdoli G. The Relapse Rates Of Addiction In Opioid Dependent Patients Under Maintenance Therapy By Naltrexone Refered To Kermanshah Rehabilitating–Treating Center. 2006.
   Google Scholar
• Maarefvand M, Eghlima M, Rafiey H, Rahgozar M, Tadayyon N, Deilamizadeh A, Ekhtiari H. Community-based relapse prevention for opiate dependents: a randomized community controlled trial. Community Mental Health J 2015;51:21–29.
   PubMed Web of Science ®Google Scholar
• Hser Y-I, Evans E, Huang D, Anglin DM. Relationship between drug treatment services, retention, and outcomes. Psychiatric Serv 2004;55:767–774.
   Google Scholar
• Beynon CM, McMinn AM, Marr AJ. Factors predicting drop out from, and retention in, specialist drug treatment services: A case control study in the North West of England. BMC Public Health 2008;8:149.
   PubMed Web of Science ®Google Scholar
• Pashaei T, Shojaeizadeh D, Foroushani AR, Ghazitabatabae M, Moeeni M, Rajati F, Razzaghi EM. Effectiveness of relapse prevention cognitive-behavioral model in opioid-dependent patients participating in the methadone maintenance treatment in Iran. Iran J Public Health 2013;42:896–902.
   PubMed Web of Science ®Google Scholar
• Schonfeld L, Peters R, Dolente A. SARA—Substance Abuse Relapse Assessment. Odessa, FL: Psychological Assessment Resources Inc; 1993.
   Google Scholar
• Turner NE, Annis HM, Sklar SM. Measurement of antecedents to drug and alcohol use: Psychometric properties of the Inventory of Drug-Taking Situations (IDTS). Behav Res Ther 1997;35:465–483.
   PubMed Web of Science ®Google Scholar
• Miller WR, Harris RJ. A simple scale of Gorski’s warning signs for relapse. J Studies Alcohol 2000;61:759–765.
   PubMed Web of Science ®Google Scholar
• Adinoff B, Talmadge C, Williams MJ, Schreffler E, Jackley PK, Krebaum SR. Time to Relapse Questionnaire (TRQ): A measure of sudden relapse in substance dependence. Am J Drug Alcohol Abuse 2010;36:140–149.
   PubMed Web of Science ®Google Scholar
• Gable RK, Wolf MB. Instrument development in the affective domain. Boston, MA: Kluwer Academic Publishers; 1993.
   Google Scholar
• Fitzner K. Reliability and validity a quick review. Diabetes Educ 2007;33:775–780.
   PubMed Web of Science ®Google Scholar
• Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychological Rep 1966;19:3–11.
   PubMed Web of Science ®Google Scholar
• Baumgartner TA, Chung H. Confidence limits for intraclass reliability coefficients. Meas Phys Educ Exercise Sci 2001;5:179–188.
   Google Scholar
• Polit DF, Beck CT. The content validity index: are you sure you know what’s being reported? Critique and recommendations. Res Nurs Health 2006;29:489–497.
   PubMed Web of Science ®Google Scholar
• Waltz CF. Measurement in nursing and health research (4 ed.). New York, NY: Springer Publishing Company; 2010.
   Google Scholar
• Lawshe CH. A quantitative approach to content validity1. Personnel Psychol 1975;28:563–575.
   Web of Science ®Google Scholar
• Lacasse Y, Godbout C, Series F. Health-related quality of life in obstructive sleep apnoea. Eur Respir J 2002;19:499–503.
   PubMed Web of Science ®Google Scholar
• Harrington D. Confirmatory factor analysis. USA: Oxford University Press; 2008.
   Google Scholar
• Mueller RO. Basic principles of structural equation modeling: An introduction to LISREL and EQS. New York, NY: Springer-Verlag; 1996.
   Google Scholar
• Kline R. Principles and practices of structural equation modeling. (2nd ed.). New York: The Guilford Press; 2005.
   Google Scholar
• Schumacker RE, Lomax RG. A beginner’s guide to structural equation modeling. Psychology Press; 2004.
   Google Scholar